{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:04:37Z","timestamp":1768363477934,"version":"3.49.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,10]]},"abstract":"<jats:p>Bladder cancer (BC) is a major global health issue, with higher incidence in males and significant regional disparities. High fasting plasma glucose (HFPG), a key metabolic risk factor, is linked to BC, but its global burden and future trends remain underexplored. We calculated the number of BC deaths, disability-adjusted life years (DALYs), age-standardized mortality rates (ASMR), and age-standardized DALY rates (ASDR) related to HFPG using data from the Global Burden of Disease 2021 database. Temporal trends were assessed using estimated annual percentage change, and inequalities were analyzed using a socio-demographic index. The Bayesian age-period-cohort model projected future burden to 2040. All analyses included 95% uncertainty intervals. In 2021, HFPG accounted for 7.9% of global BC deaths and 7.4% of DALYs. From 1990 to 2021, HFPG-related BC deaths increased by 288.3%, and DALYs increased by 263.4%. Males and older populations bore a higher burden, with ASMR and ASDR showing moderate global increases (estimated annual percentage change: 0.65 for ASMR; 0.48 for ASDR). High-income regions, particularly North America and Central Europe, had the highest ASMR and ASDR. Projections indicate a significant decline in HFPG-related BC burden by 2040, especially among males. The global burden of BC attributable to HFPG has risen significantly, with high-income regions and older males most affected. Despite projected declines by 2040, targeted prevention strategies, including lifestyle interventions and improved metabolic risk factor management, are essential to reduce future burdens and address disparities globally.<\/jats:p>","DOI":"10.1097\/md.0000000000045255","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:03:12Z","timestamp":1760331792000},"page":"e45255","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Global burden and inequalities of bladder cancer attributable to high fasting plasma glucose: Trends 1990\u20132021 and Projections to 2040"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5238-125X","authenticated-orcid":false,"given":"Mingwen","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Urology, Shaoxing Second Hospital, Shaoxing, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260113","first-page":"10","article-title":"Cancer statistics, 2025.","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"R2-20260113","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R3-20260113","doi-asserted-by":"crossref","first-page":"e004128","DOI":"10.1136\/bmjgh-2020-004128","article-title":"Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019.","volume":"6","author":"Safiri","year":"2021","journal-title":"BMJ Glob Health"},{"key":"R4-20260113","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends.","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"R5-20260113","doi-asserted-by":"crossref","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer.","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"key":"R6-20260113","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S2213-8587(20)30402-2","article-title":"Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings.","volume":"9","author":"Magliano","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R7-20260113","doi-asserted-by":"crossref","first-page":"e3572","DOI":"10.1002\/dmrr.3572","article-title":"The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990-2019: an updated analysis for the Global Burden Of Disease Study 2019.","volume":"38","author":"Liang","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"R8-20260113","doi-asserted-by":"crossref","first-page":"100261","DOI":"10.1016\/j.jnha.2024.100261","article-title":"Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the Global Burden Of Disease Study 2019.","volume":"28","author":"Wang","year":"2024","journal-title":"J Nutr Health Aging"},{"key":"R9-20260113","doi-asserted-by":"crossref","first-page":"1302436","DOI":"10.3389\/fendo.2024.1302436","article-title":"Pancreatic cancer mortality trends attributable to high fasting blood sugar over the period 1990-2019 and projections up to 2040.","volume":"15","author":"Wei","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R10-20260113","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1001\/jama.2022.3014","article-title":"The prevalence and treatment of diabetes in China from 2013 to 2018.","volume":"327","author":"Tu","year":"2022","journal-title":"JAMA"},{"key":"R11-20260113","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1186\/s12889-023-16076-x","article-title":"Global, regional, and national time trends in cancer mortality attributable to high fasting plasma glucose: an age-period cohort analysis.","volume":"23","author":"Xie","year":"2023","journal-title":"BMC Public Health"},{"key":"R12-20260113","first-page":"100082","article-title":"Transparency in the reporting of artificial intelligence \u2013 the TITAN guideline.","volume":"10","author":"Riaz","year":"2025","journal-title":"Premier J Sci"},{"key":"R13-20260113","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/S0140-6736(24)00769-4","article-title":"Findings from the Global Burden of Disease Study 2021.","volume":"403","author":"Murray","year":"2024","journal-title":"Lancet"},{"key":"R14-20260113","doi-asserted-by":"crossref","first-page":"16469","DOI":"10.1002\/cam4.6219","article-title":"Estimates of bladder cancer burden attributable to high fasting plasma glucose: findings of the Global Burden of Disease Study 2019.","volume":"12","author":"Wu","year":"2023","journal-title":"Cancer Med"},{"key":"R15-20260113","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1002\/sim.6248","article-title":"A Bayesian generalized age-period-cohort power model for cancer projections.","volume":"33","author":"J\u00fcrgens","year":"2014","journal-title":"Stat Med"},{"key":"R16-20260113","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/bimj.201500263","article-title":"Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested Laplace approximations.","volume":"59","author":"Riebler","year":"2017","journal-title":"Biom J"},{"key":"R17-20260113","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/JU.0000000000000025","article-title":"Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: results from the GBD study 2016.","volume":"201","author":"Ebrahimi","year":"2019","journal-title":"J Urol"},{"key":"R18-20260113","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women.","volume":"306","author":"Freedman","year":"2011","journal-title":"JAMA"},{"key":"R19-20260113","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer.","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"R20-20260113","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12020-016-1216-y","article-title":"Insights into the relationships between diabetes, prediabetes, and cancer.","volume":"56","author":"Scappaticcio","year":"2017","journal-title":"Endocrine"},{"key":"R21-20260113","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer.","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"R22-20260113","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00125-010-1796-7","article-title":"Diabetes, prediabetes and cancer mortality.","volume":"53","author":"Zhou","year":"2010","journal-title":"Diabetologia"},{"key":"R23-20260113","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1007\/s00125-006-0468-0","article-title":"Diabetes mellitus and risk of bladder cancer: a meta-analysis.","volume":"49","author":"Larsson","year":"2006","journal-title":"Diabetologia"},{"key":"R24-20260113","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/1471-2407-13-310","article-title":"Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies.","volume":"13","author":"Zhu","year":"2013","journal-title":"BMC Cancer"},{"key":"R25-20260113","doi-asserted-by":"crossref","first-page":"390863","DOI":"10.1155\/2015\/390863","article-title":"Diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime.","volume":"2015","author":"Joshi","year":"2015","journal-title":"Biomed Res Int"},{"key":"R26-20260113","doi-asserted-by":"crossref","first-page":"e27074","DOI":"10.1371\/journal.pone.0027074","article-title":"High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR.","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"key":"R27-20260113","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.18632\/oncotarget.13595","article-title":"Hyperglycemia triggers HIPK2 protein degradation.","volume":"8","author":"Baldari","year":"2017","journal-title":"Oncotarget"},{"key":"R28-20260113","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1756-9966-31-63","article-title":"Updates on HIPK2: a resourceful oncosuppressor for clearing cancer.","volume":"31","author":"D\u2019Orazi","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"R29-20260113","doi-asserted-by":"crossref","first-page":"18995","DOI":"10.1038\/srep18995","article-title":"High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation.","volume":"6","author":"Saengboonmee","year":"2016","journal-title":"Sci Rep"},{"key":"R30-20260113","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1159\/000373928","article-title":"High glucose promotes tumor invasion and increases metastasis-associated protein expression in human lung epithelial cells by upregulating heme oxygenase-1 via reactive oxygen species or the TGF-\u03b21\/PI3K\/Akt signaling pathway.","volume":"35","author":"Kang","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"R31-20260113","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.trsl.2014.06.010","article-title":"Heme oxygenase-1 expression is associated with tumor aggressiveness and outcomes in patients with bladder cancer: a correlation with smoking intensity.","volume":"164","author":"Miyata","year":"2014","journal-title":"Transl Res"},{"key":"R32-20260113","doi-asserted-by":"crossref","first-page":"25932","DOI":"10.18632\/oncotarget.4577","article-title":"Curcumin combined with FAP\u03b1c vaccine elicits effective antitumor response by targeting indolamine-2,3-dioxygenase and inhibiting EMT induced by TNF-\u03b1 in melanoma.","volume":"6","author":"Jiang","year":"2015","journal-title":"Oncotarget"},{"key":"R33-20260113","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.canlet.2013.12.006","article-title":"Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells.","volume":"345","author":"Guan","year":"2014","journal-title":"Cancer Lett"},{"key":"R34-20260113","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.4238\/2014.September.5.3","article-title":"Glucagon-induced angiogenesis and tumor growth through the HIF-1-VEGF-dependent pathway in hyperglycemic nude mice.","volume":"13","author":"Wang","year":"2014","journal-title":"Genet Mol Res"},{"key":"R35-20260113","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tem.2012.03.001","article-title":"Thiazolidinediones and PPAR\u03b3 agonists: time for a reassessment.","volume":"23","author":"Cariou","year":"2012","journal-title":"Trends Endocrinol Metab"},{"issue":"Suppl 1","key":"R36-20260113","doi-asserted-by":"crossref","first-page":"i57","DOI":"10.1093\/jjco\/hyq128","article-title":"Bladder cancer working group report.","volume":"40","author":"Kakehi","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"R37-20260113","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.ejcn.1602583","article-title":"Multiple socio-economic circumstances and healthy food habits.","volume":"61","author":"Lallukka","year":"2007","journal-title":"Eur J Clin Nutr"},{"key":"R38-20260113","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4239\/wjd.v6.i2.304","article-title":"Economic development and diabetes prevalence in MENA countries: Egypt and Saudi Arabia comparison.","volume":"6","author":"Sherif","year":"2015","journal-title":"World J Diabetes"},{"key":"R39-20260113","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/cam4.4917","article-title":"Racial inequity and other social disparities in the diagnosis and management of bladder cancer.","volume":"12","author":"Hasan","year":"2023","journal-title":"Cancer Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T20:02:22Z","timestamp":1768334542000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":39,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045255","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"2025-07-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}